Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.07 USD | +2.59% | +2.28% | +3.90% |
Business Summary
Number of employees: 652
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Treatment of Central Nervous System Diseases
100.0
%
| 667 | 100.0 % | 608 | 100.0 % | -8.95% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 667 | 100.0 % | 608 | 100.0 % | -8.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 30/05/30 |
Timothy Dec
DFI | Director of Finance/CFO | 66 | 23/21/23 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/05/01 |
Jonathan Rubin
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/20/01 |
Chief Tech/Sci/R&D Officer | 66 | 30/05/30 | |
Compliance Officer | 61 | 01/12/01 | |
Taylor Raiford
SAM | Sales & Marketing | - | 01/15/01 |
Todd Horich
SAM | Sales & Marketing | - | 31/18/31 |
Corporate Officer/Principal | - | 01/15/01 | |
Tami Martin
LAW | General Counsel | 68 | 01/08/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 64 | 23/15/23 |
Charles Newhall
CHM | Chairman | 79 | 30/05/30 |
John Siebert
BRD | Director/Board Member | 84 | 01/11/01 |
Frederick Hudson
BRD | Director/Board Member | 78 | 16/10/16 |
Carrolee Barlow
BRD | Director/Board Member | 60 | 27/18/27 |
Jack Khattar
FOU | Founder | 62 | 30/05/30 |
Bethany Sensenig
BRD | Director/Board Member | 48 | 21/23/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,734,956 | 51,934,710 ( 94.88 %) | 0 | 94.88 % |
Company contact information
Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
20850, Rockville
+301 838 2500
http://www.supernus.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.90% | 1.65B | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- SUPN Stock
- Company Supernus Pharmaceuticals, Inc.